Nicum S, McGregor N, Austin R, Collins L, et al. Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer. Br J Cancer 2024 Jan 20. doi: 10.1038/s41416-023-02567.
PMID: 38245661